"We started to look at the international connections from Wuhan airport and started to think: this is going to be big"
Since being appointed as CEO in October 2019, Thierry has had a baptism of fire into the top job of the $1.5B diagnostic powerhouse. We were honoured to have him join us to give us his take on the last 12 months and how he has guided QIAGEN through unprecedented challenges.
If you have any questions about this conversation or would like to get in touch with us directly, you can do so at cmconversations@charltonmorris.com
Learn more about QIAGEN here
Follow Thierry on LinkedIn here
Follow Tom on LinkedIn here
Recommended.
-
16 May 2023Lessons from Leaders in Life Science: Talking Talent Strategy.
Featuring Synda Clements, Director of Talent Acquisition at ConcertAI.
-
.jpg)
14 April 2023Bioinformatic Start-Ups Taking the Lead.
Bioinformatic development is changing the way we work. With funding developments and technology advancements expected, who should we be watching in 2023 and beyond?
-
05 April 2023Optimising to Win Top Life Sciences Talent.
Talent scarcity is hard to solve in the current climate, but developing a strategy of substance for attracting top-tier candidates is the ultimate way to stand out and win the right people. Here, I delve into how to do just that.
Comments.